English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduHusker engineer Eric Markvicka is developing a new approach for detecting acute exacerbations of chronic conditions.
Tag: COPD
UAlbany Study: Joint Effects of Thunderstorms and Power Outages Increase Respiratory-Related Emergency Department Visits
A new study led by UAlbany researchers is among the first to examine the joint effects of thunderstorms and power outages on respiratory-related emergency department visits in New York State.
Mount Sinai Experts to Present New Research on Long COVID, Lung Cancer, Asthma, Sleep Apnea, and More at ATS 2024 International Conference
Available for interview on breaking news, trending topics in respiratory medicine
New imaging software improves lung diagnosis for 30% of patients who can’t tolerate contrast dye; has added diagnostic benefits for all patients
For up to 30% of patients who are allergic to medical contrast dye or have a dye restriction because of other health conditions, they might find that it takes longer to get a diagnosis when it comes to life-threatening lung issues such as pulmonary embolism.
Cedars-Sinai Pulmonary and Critical Care Experts Present Latest Research at International Conference
Cedars-Sinai experts in pulmonology, critical care medicine and lung transplant attending the May 17-22 American Thoracic Society’s (ATS) 2024 International Conference in San Diego are available to comment on scientific advances being presented throughout the conference.
Harnessing Human Evolution to Advance Precision Medicine
Scientists hope to advance precision medicine through the discovery of a gene variant that leads to the same phenotype in separate high-dwelling populations while taking a different evolutionary path.
Pulmonary Rehabilitation Earns Strong Recommendation in New Clinical Practice Guideline
Despite its effectiveness, pulmonary rehabilitation (PR) is underused and under prescribed. The expert panel charged with developing guidance for practitioners is hopeful that the latest Clinical Practice Guideline from the American Thoracic Society will change that.
Omega-3 fatty acids promising for maintaining lung health
Omega-3 fatty acids, which are abundant in fish and fish oil supplements, appear promising for maintaining lung health, according to a Cornell-led study supported by the National Institutes of Health (NIH).
Dr. David Winter with Baylor Scott & White discusses the latest concerns about air quality in the US
David Winter, MD, at Baylor Scott & White Health, answers the most common patient questions and reacts to the latest medical research. How bad is the current air pollution in the northeastern U.S.? (SOT@ :14, TRT :42) Who is most…
Inhaled beta-2 agonists are not associated with a lower risk of Parkinson’s disease
Beta-2 agonists are bronchodilators commonly used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Hackensack University Medical Center Now Offering New, Minimally Invasive Zephyr Endobronchial Valve Treatment for Patients with Severe Emphysema
Hackensack Meridian Hackensack University Medical Center is now offering Zephyr® Endobronchial Valves, a new, minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD).
Asthma, COPD, Health Disparities Research, and Virtual Press Event: ATS 2023
We’re mere days away from the largest gathering of respiratory health professionals! You can still register to cover ATS 2023 in Washington, DC. Before you join us, here are some of the research abstracts that will be presented to this year’s gathering of pulmonary, critical care and sleep medicine health professionals.
2023 GOLD Report Proposes a New Definition of Chronic Obstructive Pulmonary Disease
Despite COPD’s pervasiveness, it is generally assumed that the main instigator in its development is tobacco smoking. The 2023 Global Initiative for Chronic Obstructive Lung Disease or GOLD report is proposing a new definition of COPD, one that acknowledges the key pathogenic role of tobacco smoking but accounts for other factors that also contribute to COPD.
Susceptibility to Pathogenic T Cells in Chronic Lung Disease May Have Genetic Basis
UC San Francisco researchers have uncovered a surprising role for fibroblasts in the lungs in activating T cell inflammation that drives lung destruction in COPD exacerbation triggered by viral infection. They also identified a T cell subset that can be targeted to treat COPD exacerbations.
A New Way to Make Asthma Drugs Last Longer
New research into making asthma and COPD medication more potent could also improve how long they work in patients who need frequent doses
World COPD Day: “Your Lungs for Life” Campaign Highlights the Importance of Lifelong Lung Health
This World COPD Day, Nov. 16, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, is supporting “Your Lungs for Life” – the campaign for a lifelong focus on keeping lungs healthy as an integral part of future health and well-being.
Inspiratory Capacity Important Marker for Disease Outcomes in COPD
Article title: Physiological predictors of morbidity and mortality in COPD: the relative importance of reduced inspiratory capacity and inspiratory muscle strength Authors: Devin B. Phillips, Matthew D. James, Conor D. O’Donnell, Sandra G. Vincent, Katherine A. Webb, Juan P. de-Torres,…
Peptide Treatment May Improve High White Blood Cell Count Associated with Smoking
Article title: Recombinant human β-defensin 2 delivery improves smoking-associated lung neutrophilia and bacterial exacerbation Authors: Nadia Milad, Marie Pineault, Gabrielle Bouffard, Michaël Maranda-Robitaille, Ariane Lechasseur, Marie-Josée Beaulieu, Sophie Aubin, Benjamin A. H. Jensen, Mathieu C. Morissette From the authors: This…
ATS Research Program Announces Partner Grant Recipients
The American Thoracic Society Research Program today announced the six recipients of the Non-Profit Partner Grants for the 2021-2022 grant cycle. These grants are awarded through partnerships with the American Lung Association, CHEST Foundation, COPD Foundation, and the Foundation for Sarcoidosis Research.
Renowned Pulmonary Disease Specialist to Lead UCSF Pulmonology Program
Prescott Woodruff, MD, MPH, a renowned leader in the pathogenesis and treatment of airway disease, has been appointed chief of UC San Francisco’s Division of Pulmonary, Critical Care, Allergy and Sleep Medicine. Prescott will assume the role of chief on July 1.
World-first study reveals why people with COPD are more susceptible to COVID-19
Researchers from the Centenary Institute and the University of Technology Sydney have published the first study showing why people with chronic obstructive pulmonary disease (COPD) are at higher risk of developing severe COVID-19.
More Coronary Disease Among COPD Patients
Patients with chronic obstructive pulmonary disease (COPD) often have other comorbid disorders, a new study from Norway shows.
Hackensack Meridian Health Seeks Disruptive Health Solutions through NJ Innovation Challenge
The Challenge seeks to reduce 30-day readmissions for: acute myocardial infarction (AMI); chronic obstructive pulmonary disease (COPD); heart failure (HF); pneumonia; coronary artery bypass graft (CABG) surgery; and elective primary total hip arthroplasty and/or total knee arthroplasty (THA/TKA).
“Lungs in a Box” Now Offered at Northwestern Medicine
Due to COVID-19 and a rapidly expanding list of conditions for which lung transplantation can be lifesaving, the need for new organs is growing. However, there’s a global shortage of donated lungs, which results in numerous deaths among patients on the waitlist. To help expand the donor pool, Northwestern Medicine is now using a device from XVIVO called XPS™ which is used for ex vivo lung perfusion (EVLP) – nicknamed “lungs in a box” – to rescue potentially viable lungs and those initially deemed “unacceptable” for transplant. Out of all solid organs, lungs have the lowest utilization, with only one in five donated lungs getting transplanted.
Researchers Unexpectedly Identify Potential Causes of Asthma, COPD
Rockville, Md. (November 8, 2021)—The activation of muscarinic acetylcholine (M2) receptors could be one of the causes of diseases like asthma and chronic obstructive pulmonary disease (COPD), according to the findings of a new study in the journal Function. The…
Scientists Pinpoint Problem Protein in Mucus
This discovery, published in the Proceedings of the National Academy of Sciences (PNAS), suggest that MUC5AC could become a target of better therapeutics to untangle the super thick and sticky mucus that plays a role in health problems for millions of people suffering from pulmonary conditions.
Study Finds Surprising Early COPD Risks for U.S. Hispanics/Latinos
A new study published online in the Annals of the American Thoracic Society provides the most exhaustive look to date at the risk factors, prevalence and population attributable risk (PAR) of developing chronic obstructive pulmonary disease (COPD) in U.S. Hispanics/Latinos under age 50. PAR estimates the proportion of disease attributable to exposure to disease-causing agents, such as smoking. The researchers used PAR to calculate the burden of early COPD that would be eliminated if the exposure did not take place.
Researchers reverse emphysema in mice by injecting blood vessel wall cells
Researchers at Weill Cornell Medicine and NewYork-Presbyterian in New York have discovered that injecting mice with pulmonary endothelial cells—the cells that line the walls of blood vessels in the lung—can reverse the symptoms of emphysema. The study, which will be published July 21 in the Journal of Experimental Medicine (JEM), may lead to new treatments for chronic obstructive pulmonary disease (COPD), an inflammatory lung disease associated with smoking that is thought to be the third leading cause of death worldwide.
Study Links COVID-19 Public Health Efforts to Dramatic Drop in COPD Hospitalizations
Public health measures designed to reduce the spread of the COVID-19 virus may have fostered a substantial side benefit: A 53 percent drop in hospital admissions for chronic obstructive pulmonary disease (COPD), likely due to a drop in circulating seasonal respiratory viruses such as influenza.
UB pharmacy researcher aims to develop real-time algorithm to lower hospital readmission rates
To lower hospital readmission rates for patients with chronic obstructive pulmonary disease (COPD), University at Buffalo pharmacy researcher David Jacobs has received a $962,000 award from the National Heart, Lung, and Blood Institute to develop a real-time readmission risk prediction algorithm.
Blocking Cell Death Protein Reduces COPD-associated Inflammation, Lung Damage
Article title: Blockade of PD-1 decreases neutrophilic inflammation and lung damage in experimental COPD Authors Felix Ritzmann, Kai Borchardt, Giovanna Vella, Praneeth Chitirala, Adrian Angenendt, Christian Herr, Michael D. Menger, Markus Hoth, Annette Lis, Rainer M Bohle, Robert Bals, Christoph…
Nearly $500 million a year in Medicare costs goes to 7 services with no net health benefits
A UCLA-led study shows that physicians frequently order preventive medical services for adult Medicare beneficiaries that are considered unnecessary and of “low value” by the U.S. Preventive Services Task Force — at a cost of $478 million per year.
Amoeba Biology Reveals Potential Treatment Target for Lung Disease
In a series of experiments that began with amoebas — single-celled organisms that extend podlike appendages to move around — Johns Hopkins Medicine scientists say they have identified a genetic pathway that could be activated to help sweep out mucus from the lungs of people with chronic obstructive pulmonary disease a widespread lung ailment.
New strategy blocks chronic lung disease in mice
A new study from Washington University School of Medicine in St. Louis has uncovered a previously unknown role for exosomes in inflammatory respiratory diseases. The study has implications for finding new therapies. Exosomes are tiny compartments released from cells that carry different types of cargo, including inflammatory chemicals called cytokines that can drive lung disease.
NIH study shows hyaluronan is effective in treating chronic lung disease
NIH researchers and their collaborators found that inhaling unfragmented hyaluronan improves lung function in patients suffering from severe exacerbation of COPD. Hyaluronan is a sugar secreted by living tissue that acts as a scaffold for cells. Utilized as a treatment, hyaluronan decreased the number of days in the hospital.
Living Well with COPD – Everybody, Everywhere: The Forum of International Respiratory Societies
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease that causes breathlessness, chronic sputum production and cough. There are 300 million current cases of COPD in the world. COPD is currently the third leading cause of death globally and is highly prevalent in low resource countries. Exposure to tobacco smoke and other inhaled toxic particles and gases are the main risk factors for COPD, although recent research has identified that suboptimal lung growth before and after birth can also increase the risk of COPD later in life.
Home Oxygen Therapy for Adults with COPD and ILD: New ATS Clinical Practice Guideline
The latest clinical practice guideline on home oxygen therapy addresses long-term and ambulatory oxygen therapy for adults with chronic obstructive pulmonary disease and interstitial lung disease and includes the most comprehensive review of the evidence of any oxygen guideline to date.
New Research Bolsters Link between Prenatal Smoking and Impaired Lung Development
Babies born to mothers who smoked during pregnancy are more likely to suffer from impaired lung development. They are also more susceptible to developing lung diseases such as asthma and chronic obstructive pulmonary disease (COPD).
ATS Research Program, 4DMedical Announce Grant Opportunities for Research in Asthma, COPD and IPF
Today, the ATS Research Program announced three research grant opportunities with support from 4DMedical, a global medical technology company with a focus on lung health. With a total grant support of $150,000, each of the three $50,000 grants will fund research in asthma, chronic obstructive pulmonary disorder or COPD, and idiopathic pulmonary fibrosis or IPF.
Protein Produced by the Nervous System May Help Treatments for Inflammatory Diseases
A Rutgers-led team may have found the key to treating inflammatory diseases like asthma, allergies, chronic fibrosis and chronic obstructive pulmonary disease (COPD).
New Clinical Practice Guidelines on Non-Invasive Ventilation in Chronic Stable Hypercapnic COPD;
A subcommittee of the American Thoracic Society Assembly in Sleep and Respiratory Neurobiology has released new clinical practice guidelines to help advise clinicians on the optimal management of patients with chronic obstructive pulmonary disease (COPD) and chronic hypercapnia. Hypercapnia is the buildup of carbon dioxide in the bloodstream.
Baylor Scott & White Health Again Recognized as Most Awarded Not-for-profit Health System in Texas by U.S. News & World Report
In the midst of the extraordinary health challenge presented by the COVID-19 pandemic, Baylor Scott & White Health remains committed to quality, safe care and helping Texas communities navigate the uncertainty of the SARS-CoV-2 virus. Today, this commitment to safety and quality is recognized as U.S. News & World Report releases its 2020-2021 Best Hospitals list.
Abated Breath: From COVID-19 to Wildfire Smoke and Air Pollution, Multiple Factors Threaten Lung Health This Summer
As we continue to grapple with the global pandemic, rising summer temperatures and wildfire season pose new challenges to our lung health. A team of pulmonologists and researchers at UC San Diego Health offer a wide variety of expertise and…
Asthma Does Not Seem to Increase the Severity of COVID-19
Asthma does not appear to increase the risk for a person contracting COVID-19 or influence its severity, according to a team of Rutgers researchers.
Clearing the Air on E-Cigarettes
Researchers at The University of Kansas Cancer Center are studying vaping to better understand its effects on our health, as well as reduce vaping among adolescents.
Breathing During Exercise Is Harder for Women Than Men
While both sexes have the capacity for phenomenal athletic achievements, women on average must work harder to breathe during strenuous exercise compared to men, according to new research.
LABA/LAMA Combination Therapy More Effective for COPD Patients with Exercise Intolerance
Clinicians grappling with the pharmacologic management of COPD in patients complaining of exercise intolerance or dyspnea now have new guidance. The American Thoracic Society has published an official clinical practice guideline in which a panel of experts strongly recommended LABA/LAMA combination therapy over LABA or LAMA alone. The complete guideline detailing all the recommendations was posted online ahead of print in the American Journal of Respiratory and Critical Care Medicine.
COVID-19 and chronic lung disease: How to stay safe
Because COVID-19 attacks the lungs, limiting social contact is extremely important for people who have underlying health conditions such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and any additional chronic lung illness.
Three-Drug Combination Reduces COPD Patient Mortality
Once-daily treatment of patients with chronic obstructive pulmonary disease (COPD) with an inhaler combining fluticasone furoate (FF), umeclidinium (UMEC) and vilanterol (VI) reduced all-cause mortality by 42 percent, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
UK Study Highlights Importance of Spirometry in Diagnosing COPD, Versus Over-Reliance on Medical Imaging
A UK study of patients participating in low-dose CT lung cancer screening highlights the importance of spirometry (breathing tests) in the assessment of possible chronic obstructive pulmonary disease (COPD), and demonstrates that over-reliance on radiological changes alone may result in detection of clinically insignificant disease. The new study is published online in the Annals of the American Thoracic Society.